Yung Zip Chemical Ind (4102) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 永日

Yung Zip Chemical Ind (4102) reported revenue of NT$40.1 million for Oct 2026, +15.3% year on year and +28.3% from the previous month. Revenue for Jan–Oct 2026 was NT$424.3 million (+7.4% year on year).

In Oct 2026, it ranked No. 108 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$27 million24/10Nov 2024 NT$31.9 millionDec 2024 NT$43.4 millionJan 2025 NT$36.9 millionFeb 2025 NT$42.3 million25/02Mar 2025 NT$49.7 millionApr 2025 NT$45.1 millionMay 2025 NT$37.9 millionJun 2025 NT$44.2 million25/06Jul 2025 NT$35.7 millionAug 2025 NT$32.9 millionSep 2025 NT$35.6 millionOct 2025 NT$34.7 million25/10Nov 2025 NT$32.7 millionDec 2025 NT$46.4 millionJan 2026 NT$52.3 millionFeb 2026 NT$25.7 million26/02Mar 2026 NT$45.1 millionApr 2026 NT$37.3 millionMay 2026 NT$48.4 millionJun 2026 NT$67.1 million26/06Jul 2026 NT$41.7 millionAug 2026 NT$35.3 millionSep 2026 NT$31.2 millionOct 2026 NT$40.1 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$40.1 million+15.3%+28.3%
Sep 2026NT$31.2 million-12.2%-11.6%
Aug 2026NT$35.3 million+7.5%-15.3%
Jul 2026NT$41.7 million+16.7%-37.9%
Jun 2026NT$67.1 million+51.9%+38.7%
May 2026NT$48.4 million+27.7%+29.9%
Apr 2026NT$37.3 million-17.4%-17.4%
Mar 2026NT$45.1 million-9.2%+75.4%
Feb 2026NT$25.7 million-39.2%-50.8%
Jan 2026NT$52.3 million+41.6%+12.6%
Dec 2025NT$46.4 million+6.9%+42.1%
Nov 2025NT$32.7 million+2.5%-5.9%
Oct 2025NT$34.7 million+28.9%-2.3%
Sep 2025NT$35.6 million+2.7%+8.2%
Aug 2025NT$32.9 million-45.4%-8.0%
Jul 2025NT$35.7 million-42.2%-19.2%
Jun 2025NT$44.2 million+8.9%+16.5%
May 2025NT$37.9 million-44.4%-16.0%
Apr 2025NT$45.1 million-31.3%-9.1%
Mar 2025NT$49.7 million+4.2%+17.4%
Feb 2025NT$42.3 million+26.0%+14.6%
Jan 2025NT$36.9 million-46.4%-15.0%
Dec 2024NT$43.4 million-5.0%+36.3%
Nov 2024NT$31.9 million-54.7%+18.3%
Oct 2024NT$27 million-20.5%-22.2%

Jan–Oct 2026 cumulative: NT$424.3 million (+7.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Yung Zip Chemical Ind vs PEC / Yung Zip Chemical Ind vs Lotus Pharm / Yung Zip Chemical Ind vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16